Read Pharmafocus January/February 2019 edition online now!

pharmafile | January 30, 2019 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Cancer, Counterfeit drugs, NHS, Pharmafocus, WHO, brexit, pharma, vaccines 

We’re slowly edging towards warmer months, but the New Year brings more than just the promise of more amicable weather; in a manner reminiscent of past years, industry M&A is off to an explosive start, as multinational drug firm Bristol-Myers Squibb announced within the first days of the year that it had entered into an agreement to acquire Celgene for approximately $74 billion – the biggest pharma acquisition ever. You can read the full story on our front page.

Elsewhere, the World Health Organization has revealed an annual list of what it considers to be the greatest threats to global health, and there were a few surprises alongside expected dangers such as antimicrobial resistance, HIV and weak primary healthcare, including air pollution, climate change and vaccine hesitancy.  You can find the full list on page 7.

In R&D, new research has promised to fight cancer in a way that almost borders on science fiction: by converting the tumour’s cells into fat. You can read about the project, as well as exclusive commentary from the paper’s lead author Dana Ishay Ronen, on page 8. You can find these stories and many more in our latest issue.

Also, be sure not to miss our full-length features exploring how artificial intelligence can address the industry’s drug development challenges, and why the counterfeit drugs problem is not what it seems.  

Read the January/February edition of Pharmafocus online now!

Related Content

Scientists use AI to find new antibiotic to fight superbug

Scientists at McMaster University and the Massachusetts Institute of Technology (MIT) have utilised artificial intelligence …


AstraZeneca shares oncology data at ASCO 2023

AstraZeneca plans to share data from its oncology pipeline at the American Society of Clinical …


NHS given guidance on offering genetic testing to stroke patients

The NHS has been given draft guidance on offering gene tests to patients who have …

Latest content